TL;DR: Granza Bio is a Y Combinator Winter 2024 startup Building programmable therapeutics for the immune system, currently active with a team of 8.
Building programmable therapeutics for the immune system
Last verified:
Granza Bio is developing programmable therapeutics for the immune system. Our platform is built on the foundational discovery of immune “superkiller” attack particles — the natural ammunition used by cytotoxic immune cells to deliver potent, localized killing. By re-arming exhausted immune cells with newly programmed ammunition, Granza restores and enhances immune function. This approach enables a new class of treatments with the potential to transform diseases ranging from cancer to autoimmunity.
Built by LemStudio
Yes. Granza Bio was funded by Y Combinator in the Winter 2024 batch. Building programmable therapeutics for the immune system
Granza Bio is developing programmable therapeutics for the immune system. Our platform is built on the foundational discovery of immune “superkiller” attack particles — the natural ammunition used by cytotoxic immune cells to deliver potent, localized killing. By re-arming exhausted immune cells with newly programmed…
Granza Bio was part of Y Combinator's Winter 2024 batch.
Granza Bio has a team of 8 people according to Y Combinator's directory.
Granza Bio is currently listed as Active with a team of 8 in Y Combinator's directory.
Loading interactive view…